buyModerate cluster of 7
Sr One Capital Management, LLC bought $10.0M of ODTX
owner at Odyssey Therapeutics, Inc.. 555,555 shares at an average of $18.00, traded May 11, 2026, filed May 11, 2026.
Conviction score
53Value
$10.0M
555,555 shares
Holdings after
1,014,851
+35% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +25Trade size$10.0M at market
- +6Relative to holdingsHoldings up 35%
- 0Price contextNo price history yet
- +15Cluster7 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
ODTXOct 12, 2026 · close 18.26
Since filing May 11, 2026: +4.6%SPY +5.8% · excess -1.1%
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-217656, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 11, 2026 | CConversion Common Stockindirect: See Note 2 | +474,048 | - | - | 474,048 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 2 | +139,366 | - | - | 613,414 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 2 | +59,692 | - | - | 673,106 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 2 | +61,762 | - | - | 734,868 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 2 | +683,817 | - | - | 1,418,685 | May 11, 2026 |
| May 11, 2026 | XIn-the-money exercise Common Stockindirect: See Note 2 | +191,541 | - | - | 1,610,226 | May 11, 2026 |
| May 11, 2026 | SOpen-market sale Common Stockindirect: See Note 2 | -1,065 | $18.00 | $19k | 1,609,161 | May 11, 2026 |
| May 11, 2026 | POpen-market purchase Common Stockindirect: See Note 2 | +222,222 | $18.00 | $4.0M | 1,831,383 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 9 | +118,512 | - | - | 118,512 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 9 | +255,823 | - | - | 374,335 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 10 | +204,658 | - | - | 204,658 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 10 | +20,582 | - | - | 225,240 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 10 | +166,168 | - | - | 391,408 | May 11, 2026 |
| May 11, 2026 | XIn-the-money exercise Common Stockindirect: See Note 10 | +49,850 | - | - | 441,258 | May 11, 2026 |
| May 11, 2026 | SOpen-market sale Common Stockindirect: See Note 10 | -277 | $18.00 | $4,986 | 440,981 | May 11, 2026 |
| May 11, 2026 | POpen-market purchase Common Stockindirect: See Note 10 | +133,333 | $18.00 | $2.4M | 574,314 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 12 | +463,106 | - | - | 463,106 | May 11, 2026 |
| May 11, 2026 | CConversion Common Stockindirect: See Note 12 | +273,527 | - | - | 736,633 | May 11, 2026 |
| May 11, 2026 | XIn-the-money exercise Common Stockindirect: See Note 12 | +78,656 | - | - | 815,289 | May 11, 2026 |
| May 11, 2026 | SOpen-market sale Common Stockindirect: See Note 12 | -438 | $18.00 | $7,884 | 814,851 | May 11, 2026 |
| May 11, 2026 | POpen-market purchase Common Stockindirect: See Note 12 | +200,000 | $18.00 | $3.6M | 1,014,851 | May 11, 2026 |
| May 11, 2026 | CConversion Series A Convertible Preferred Stockderivativeindirect: See Note 2 | -4,606,320 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series A-2 Convertible Preferred Stockderivativeindirect: See Note 2 | -1,299,842 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series B Convertible Preferred Stockderivativeindirect: See Note 2 | -544,162 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series C Convertible Preferred Stockderivativeindirect: See Note 2 | -600,142 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series D Convertible Preferred Stockderivativeindirect: See Note 2 | -6,644,650 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | XIn-the-money exercise Series D Warrants (Right to Buy)derivativeindirect: See Note 2 | -1,861,211 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series A Convertible Preferred Stockderivativeindirect: See Note 9 | -1,151,580 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series B Convertible Preferred Stockderivativeindirect: See Note 9 | -2,374,981 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series B Convertible Preferred Stockderivativeindirect: See Note 10 | -1,899,984 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series C Convertible Preferred Stockderivativeindirect: See Note 10 | -200,000 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series D Convertible Preferred Stockderivativeindirect: See Note 10 | -1,614,650 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | XIn-the-money exercise Series D Warrants (Right to Buy)derivativeindirect: See Note 10 | -484,395 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series C Convertible Preferred Stockderivativeindirect: See Note 12 | -4,500,000 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | CConversion Series D Convertible Preferred Stockderivativeindirect: See Note 12 | -2,657,860 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | XIn-the-money exercise Series D Warrants (Right to Buy)derivativeindirect: See Note 12 | -764,312 | $0.00 | $0 | 0 | May 11, 2026 |
Related signals
Other insiders at Odyssey Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | Odyssey Therapeutics, Inc. | Tpg Gp A, LLC other | $25M 1,388,889 shares | +60% | |
| 61Notable | Odyssey Therapeutics, Inc. | Dimension Capital II, L.P. director | $20M 1,111,111 shares | +50% | |
| 50Moderate | Odyssey Therapeutics, Inc. | Shelley Chu director | $200k 11,111 shares | - | |
| 17Weak | ODTXsell Odyssey Therapeutics, Inc. | Sr One Capital Management, LLC owner | $32k 1,780 shares | -0% | |
| 37Weak | Odyssey Therapeutics, Inc. | Jason Haas Chief Financial Officer | $20k 1,000 shares | +2% | |
| 40Moderate | Odyssey Therapeutics, Inc. | Jeffrey M Leiden director | $100k 5,000 shares | +2% | |
| 61Notable | Odyssey Therapeutics, Inc. | Nan (LN) Li director | $20M 1,111,111 shares | +50% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.